Latest Articles

Publication Date
Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma - BMC Cancer

Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma BMC Cancer

Published: Oct. 9, 2025, 1:10 p.m.
Case Report: A patient with lynch syndrome with vaginal endometriosis-associated malignancy and synchronous colonic tubulovillous adenoma.

Endometriosis is a common gynecological condition. However, endometriosis-associated malignancies occur in up to 1% of women with endometriosis. Most cases of endometriosis-associated malignancy occur in the ovary, whereas 20% of …

Published: Oct. 8, 2025, midnight
ACOXL-AS1’s pan-cancer dynamics and its proliferative impact on endometrial endometrioid carcinoma - BMC Cancer

ACOXL-AS1’s pan-cancer dynamics and its proliferative impact on endometrial endometrioid carcinoma BMC Cancer

Published: Oct. 6, 2025, 2:30 p.m.
Clinical, Metabolic, and Sonographic Predictors of Endometrial Carcinoma Among Women Presenting With Postmenopausal Bleeding: A Prospective Observational Study From a Tertiary Care Center in South India - Cureus

Clinical, Metabolic, and Sonographic Predictors of Endometrial Carcinoma Among Women Presenting With Postmenopausal Bleeding: A Prospective Observational Study From a Tertiary Care Center in South India Cureus

Published: Oct. 4, 2025, 11:16 a.m.
Erythema ab igne-A Potential Cutaneous Marker of Chronic Heat Use in Patients with Endometriosis: A Narrative Literature Review and a Case Report.

Erythema ab igne (EAI), also known as "hot water bottle rash" or "toasted skin syndrome", is a benign cutaneous condition caused by chronic exposure to low-level infrared heat. It typically …

Published: Sept. 29, 2025, midnight
Clinicopathological Characteristics and Oncologic Outcomes of Endometrioid Ovarian Carcinoma: A Retrospective Study from a Tertiary Cancer Centre.

Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medical records of …

Published: Sept. 28, 2025, midnight
Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma - Frontiers

Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma Frontiers

Published: Sept. 25, 2025, 5:47 p.m.
Ovarian endometrioid tumor occurring in a patient with early-stage, low-risk endometrial carcinoma successfully treated by fertility-sparing management: a case report - Frontiers

Ovarian endometrioid tumor occurring in a patient with early-stage, low-risk endometrial carcinoma successfully treated by fertility-sparing management: a case report Frontiers

Published: Sept. 24, 2025, 9:48 a.m.
Microfibril-associated protein 2 interacts with LEF1/TCF7 and immune infiltration in uterine corpus endometrial carcinoma - Termedia

Microfibril-associated protein 2 interacts with LEF1/TCF7 and immune infiltration in uterine corpus endometrial carcinoma Termedia

Published: Sept. 15, 2025, 1:33 p.m.
FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation - Nature

FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation Nature

Published: Sept. 13, 2025, 5:58 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!